While DNR alone increased the expression of both markers in both cell lines, co-treatment with M3814 further enhanced their expression, indicating that DNA-PK inhibitor acts as a booster of DNR induced AML differentiation. This evidence concerns the gene PRKDC and acute myeloid leukemia.